PBM has been previously demonstrated to induce synaptic resilience to Aβ oligomer toxicity, increase synaptic autophagy, and facilitate reductions in oligomeric tau accumulation in animal models of amyloidosis and tauopathy, and in a middle-aged 3xTg-AD mouse model [17,18]. The gene discussed is MAPT; the disease is Alzheimer disease.